Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability

Cell

Volumn 86, Issue 2, 1996, Pages 209-219

  Coetzee, Timothy ^a   Fujita, Nobuya ^a   Dupree, Jeffrey ^a   Shi, Riyi ^a   Blight, Andrew ^a   Suzuki, Kinuko ^a   Suzuki, Kunihiko ^a,b   Popko, Brian ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; GALACTOSYLTRANSFERASE; MYELIN PROTEIN; URIDINE DIPHOSPHATE GALACTOSE;

ANIMAL CELL; ARTICLE; ATAXIA; CELL ULTRASTRUCTURE; CELL VACUOLE; ELECTRON MICROSCOPY; GENETIC STABILITY; MEMBRANE BINDING; MOUSE; MYELINATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030602822     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80093-8     Document Type: Article

References (65)

1. Abramson, M.B., Norton, W.T., and Katzman, R. (1965). Study of ionic structure in phospholipids by infrared spectra. J. Biol. Chem. 240, 2389-2395.
2. Adachi, M., Torii, J., Schneck, L., and Volk, B.W. (1972). Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (Van Bogaert and Bertrand type). Acta. Neuropathol. 20, 22-31.
3. Adlkofer, K., Martinin, R., Aguzzi, A., Zielasek, J., Toyka, K.V., and Suter, U. (1995). Hypermyelination and demylinating peripheral neuropathy in Pmp-22-deficient mice. Nature Genet. 11, 274-280.
4. Aleu, F.R., Katzman, R., and Terry, R.D. (1963). Fine structure and electrolyte analysis of cerebral edema induced by alkyltin intoxication. J. Neuropathol. Exp. Neurol. 22, 403-413.
5. Bansal, R., and Pfeiffer, S. (1989). Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc. Natl. Acad. Sci. USA 86, 6181-6185.
6. Barrett, E.F., and Barrett, J.N. (1982). Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J. Physiol. 323, 117-144.
7. Beaudet, A.L. (1995). Aspartoacylase deficiency (Canavan Disease). In The Metabolic and Molecular Basis of Inherited Disease, 7th Edition. C.R. Scriber, A.L. Beaudet, W.S. Sly, and D. Valle, eds. (New York: McGraw Hill, Inc.), pp. 4599-4605.
8. Benjamins, J.A., and Dyer, C.A. (1990). Glycolipids and transmembrane signaling in oligodendroglia. Ann. NY Acad. Sci. 605, 90-100.
9. Black, J.A., Kocsis, J.D., and Waxman, S.G. (1990). Ion channel organization of the myelinated fiber. Trends Neurosci. 13, 48-54.
10. Blight, A.R. (1985). Computer simulation of action potentials and afterpotentials in mammalian myelinated axons: the case for a lower resistance myelin sheath. Neuroscience 15, 13-31.
11. Boison, E., and Stoffel, W. (1994). Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. USA 91, 11709-11713.
12. Buschard, K., Josefsen, K., Hansen, S.V., Thorn, T., Marshall, M.O., Persson, H., Mansson, J.-E., and Fredman, P. (1994). Sulphatide in islets of Langerhans and in organs affected in diabetic late complications: a study in human and animal tissue. Diabetologia 37, 1000-1006.
13. Campagnoni, A.T., and Macklin, W.B. (1988). Cellular and molecular aspects of myelin protein gene expression. Mol. Neurobiol. 2, 41-89.
14. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
15. Coetzee, T., Li, X., Fujita, N., Marcus, J., Suzuki, K., Francke, U., and Popko, B. (1996). Molecular cloning, chromosomal mapping, and characterization of the mouse UDP-galactose:ceramide galactosyltransferase gene. Genomics, in press.
16. Costantino-Ceccarini, E., and Morell, P. (1973). Synthesis of galactosylceramide and glucosylceramide by mouse kidney preparations. J. Biol. Chem. 248, 8240-8246.
17. Curalto, W. (1987). Glycolipid function. Biochim. Biophys. Acta 906, 137-160.
18. David, G., Modney, B., Scappaticci, K.A., Barrett, J.N., and Barrett, E.F. (1995). Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J. Physiol. 489, 141-157.
19. De Vries, G.H., Norton, W.T., and Raine, C.S. (1972). Axons: isolation from mammalian central nervous system. Science 175, 1370-1372.
20. Dorfman, S., Fry, J., and Silberberg, D. (1979). Antiserum induced myelination inhibition in vitro without complement. Brain Res. 177, 105-114.
21. Dyer, C.A. (1993). Novel oligodendrocyte transmembrane signaling systems. Mol. Neurobiol. 7, 1-22.
22. Dyer, C.A., and Benjamins, J.A. (1988). Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J. Neurosci. 9, 4307-4310.
23. Dyer, C.A., and Benjamins, J.A. (1989). Organization of oligodendroglial membrane sheets. II: galactocerebroside:antibody interactions signal changes in cytoskeleton and myelin basic protein. J. Neurosci. Res. 24, 212-221.
24. Dyer, C.A., and Benjamins, J.A. (1990). Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause a calcium influx in oligodendrocytes. J. Cell Biol. 111, 625-633.
25. 2+ responses in oligodendrocytes. J. Neurosci. Res. 30, 699-711.
26. Folch-Pi, J., Lees, M.B., and Sloane-Stanley, G.H. (1957). A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226, 497-509.
27. Frankenhaeuser, B., and Moore, L.E. (1963). The effect of temperature on the sodium and potassium permeability changes in myelinated nerve fibers of Xenopus laevis. J. Physiol. 169, 431-437.
28. Fry, J.M., Weissbarth, S., and Lehrer, G.M. (1974). Cerebroside antibody inhibits sulfatide synthesis and myelination and demyelinates in cord tissue cultures. Science 183, 540-542.
29. Fujita, N., Suzuki, K., Vanier, M.T., Popko, B., Maeda, N., Klein, A., Henseler, M., Sandhoff, K., Nakayasu, H., Suzuki, K. (1996). Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Human Molec. Genet. 5, 711-725.
30. 0 gene in mice leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565-576.
31. Hammarström, S. (1971). Brain glucosyl ceramides containing 2-hydroxyacids: identification of molecular species by gas-liquid chromatography-mass spectrometry. Eur. J. Biochem. 21, 388-392.
32. Harouse, J.M., Bhat, S., Spitalnik, L., Laughlin, M., Stefeno, K., Silverberg, D.H., and Gonzalez-Scarano, F. (1991). Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253, 320-323.
33. Igisu, H., Takahashi, H., Suzuki, K., and Suzuki, K. (1983). Abnormal accumulation of galactosylceramide in the kidney of twitcher mouse. Biochem. Biophys. Res. Commun. 110, 940-944.
34. Jansen, R., and Ledley, F.D. (1989). Production of discrete high specific activity DNA probes using polymerase chain reaction. Genet. Anal. Tech. Appl. 6, 79-83.
35. Koynova, R., and Caffrey, M. (1995). Phases and phase transitions of the sphingolipids. Biochim. Biophys. Acta 1255, 213-236.
36. Li, C., Tropak, M.B., Gerlai, R., Clapoff, S., Abramow-Newerly, W., Trapp, B., Peterson, A., and Roder, J. (1994). Myelination in the absence of myelin-associated glycoprotein. Nature 369, 747-750.
37. Little, G.J., and Heath, J.W. (1994). Morphometric analysis of axons myelinated during adult life in the mouse superior cervical ganglion. J. Anat. 184, 387-398.
38. Long, D., Berson, J.F., Cook, D.G., and Doms, R.W. (1994). Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J. Virol. 68, 5890-5898.
39. Lunn, K.F., Fanarraga, M.L., and Duncan, I.D. (1995). Myelin mutants: new models and new observations. Micros. Res. Tech. 32, 183-203.
40. Milner, R.J., Lai, C., Nave, K., Lenoir, D., Ogata, J., and Sutcliffe, J.G. (1985). Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 42, 931-939.
41. Montag, D., Giese, K.P., Bartsch, U., Martini, R., Lang, Y., Blüthmann, H., Karthigasan, J., Kirschner, D.A., Wintergerst, E.S., Nave, K., Zielasek, J., Toyka, K.V., Lipp, H., and Schachner, M. (1994). Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13, 229-246.
42. Morell, P., and Radin, N.S. (1969). Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acid. Biochemistry 8, 506-512.
43. Morell, P., Quarles, R.H., and Norton, W.T. (1994). Myelin formation, structure, and biochemistry. In Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. G.J. Siegel, B.W. Agranoff, R.W. Albers, and P.B. Molinoff, eds. (New York: Raven Press), pp. 117-143.
44. Neskovic, N.M., Roussel, G., and Nussbaum, J.L. (1986). UDP-galactose:ceramide galactosyltransferase of rat brain: a new method of purification and production of specific antibodies. J. Neurochem. 47, 1412-1418.
45. Norton, W.T., and Cammer, W. (1984). Isolation and characterization of myelin. In Myelin. P. Morell, ed. (New York: Plenum Press), pp. 147-195.
46. Norton, W.T., and Poduslo, S.E. (1973). Myelination in rat brain: method of myelin isolation. J. Neurochem. 21, 749-757.
47. Pfeiffer, S.E., Warrington, A.E., and Bansal, R. (1993). The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3, 191-197.
48. Popko, B., Puckett, C., Lai, E., Shine, H.D., Readhead, C., Takahashi, N., Hunt, S.W.I., Sidman, R.L., and Hood, L. (1987). Myelin deficient mice: expression of myelin basic protein and generation of mice with varying levels of myelin. Cell 48, 713-721.
49. Ranscht, B., Wood, P.M., and Bunge, R.P. (1987). Inhibition of in vitro peripheral myelin formation by monoclonal anti-galactocerebroside. J. Neurosci. 7, 2936-2947.
50. Rath, E.M., Kelly, D., Bouldin, T.W., Popko, B. (1995). Impaired peripheral nerve regeneration in a mutant strain of mice (Enr) with a Schwann cell defect. J. Neurosci. 15, 7226-7237.
51. Readhead, C., Popko, B., Takashi, N., Shine, H.D., Saavedra, R.A., Sidman, R.L., Hood, L. (1987). Expression of myelin basic protein in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 48, 703-712.
52. Roach, A., Boylan, K., Horvath, S., Prusiner, S.B., and Hood, L. (1983). Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 42, 799-806.
53. Rosenbluth, J., Liu, Z., Guo, D., and Schiff, R. (1994). Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells. J. Neurocytol. 23, 699-707.
54. Schaeren-Wiemers, N., vander Bijl, P., and Schwab, M.D. (1995). The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide. J. Neurochem. 65, 2267-2278.
55. Schulte, S., and Stoffel, W. (1993). Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning and expression. Proc. Natl. Acad. Sci. USA 90, 10265-10269.
56. Shine, H.D., Readhead, C., Popko, B., Hood, L., Sidman, R.L. (1992). Morphometric analysis of normal, mutant, and transgenic CNS: correlation of myelin basic protein expression to myelogenesis. J. Neurochem. 58, 342-349.
57. Stahl, N., Jurevics, H., Morell, P., Suzuki, K., and Popko, B. (1994). Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose:ceramide galactosyltransferase. J. Neurosci. Res. 38, 234-242.
58. Sutcliffe, J.G., Milner, R.J., Shinnick, T.M., and Bloom, F.E. (1983). Identifying the protein products of brain-specific genes with antibodies to chemically synthesized peptides. Cell 33, 671-682.
59. Suzuki, K., and Kikkawa, Y. (1969). Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclopexanone oxalyldihydrazone). Am. J. Pathol. 54, 307-325.
60. Towfighi, J. (1980). Hexachlorophene. In Experimental and Clinical Neurotoxicology. P.S. Spencer and H.H. Schaumburg, eds. (Baltimore: Williams and Wilkins), pp. 440-455.
61. Towfighi, J., Gonatas, N.K., and McCree, L. (1974). Hexachlorophene-induced changes in central and peripheral myelinated axons of developing and adult rats. Lab Invest. 31, 712-721.
62. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
63. Watanabe, I. (1980). Organotins. In Experimental and Clinical Neurotoxicology. P.S. Spencer and H.H. Schaumburg, eds. (Baltimore: Williams and Wilkins), pp. 545-557.
64. Waxman, S.G., and Ritchie, J.M. (1993). Molecular dissection of the myelinated axon. Ann. Neurol. 33, 121-136.
65. Yahi, N.S., Baghdiguian, S., Moreau, H., and Fantini, J. (1992). Galactosyl ceramide (or closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66, 4848-4859.